Nasdaq

Arcutis : ZORYVE Cream 0.15% Improves Atopic Dermatitis Across Skin Types In Phase 3 Trials

(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...
Nasdaq

CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105

SCENESSE® is being evaluated as a systemic repigmentation therapy for vitiligo patients, with a clinical focus on adolescent (12 years and above) and adult patients with darker skin types (Fitzpatrick ...
Business Insider

New Data Shows ZORYVE® (Roflumilast) Cream 0.15% Provided Consistent Improvement of Atopic Dermatitis in Individuals With Diverse Skin Types

ZORYVE demonstrated consistent efficacy in disease clearance and reduction in itch for individuals with atopic dermatitis (AD) regardless of race, ethnicity, and Fitzpatrick skin type ZORYVE was safe ...
Medscape

Fractional CO2 Laser Shows Promise in Treating Postburn Hypertrophic Scars in Skin of Color

In a cohort study, fractional CO2 laser therapy was effective in treating postburn hypertrophic scars, with significant improvements in scar vascularity, pigmentation, and pliability across ...
Healio

Mineral sunscreen moisturizer offers positive cosmetic outcomes across skin types

Please provide your email address to receive an email when new articles are posted on . After 12 weeks, researchers observed a 23.4% improvement in overall photodamage in Fitzpatrick skin types I to ...